Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Why Is My Budget Not Working helps you pinpoint where spending misaligns with goals and how to adjust for consistent progress.
27,172 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
BYD claims a dramatic leap in charging speed that could reshape the EV landscape. This article unpacks what that mean...
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Clorox has stacked a long streak of dividend increases, but reaching 50 years could hinge on a crucial strategic shif...
A new payment option is pushing into the spotlight without fanfare. Pay-by-bank quietly gaining ground challenges the...
RH has endured a steep decline over five years. This article breaks down whether the luxury home brand can stage a re...
A rising labor union participation rise is reshaping the U.S. workforce, with more workers joining unions while emplo...
As Treace Medical eyes 2026, investors weigh adoption of Lapiplasty, payer dynamics, and global expansion. This guide...
A veteran program manager at a leading mortgage tech firm is accelerating digital lending by turning strategic plans ...
SpaceX stunned markets with a massive IPO haul and a rapid follow-up bond issue. This article breaks down what happen...
The iconic Atari brand is tapping public investors to back the first Atari Hotel, a Phoenix project blending gaming, ...
Two heavyweights vie for leadership in AI cooling and data-center resilience. This guide breaks down which stock—NVEN...